首页> 外文期刊>亚洲男性学杂志(英文版) >Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations
【24h】

Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations

机译:改良的TNM分期系统在中国东部透明细胞肾细胞癌中的应用:优势与局限性

获取原文
获取原文并翻译 | 示例
       

摘要

This study was designed to evaluate whether the revised 2010 Tumour Node Metastasis (TNM) staging system could lead to a more accurate prediction of the prognosis of renal cell carcinoma (RCC) patients.A total of 1216 patients who had undergone radical nephrectomy or partial nephrectomy for RCC from 2003 to 2011 were enrolled.All of the patients had pathologically confirmed clear cell RCC (ccRCC).All cases were staged by both the 2002 and 2010 TNM staging systems after pathological review,and survival data were collected.Univariate and multivariate Cox regression models were used to evaluate cancer-specific survival (CSS) and progression-free survival (PFS) after surgery.Continuous variables,such as age and tumour diameter,were calculated as mean values and standard deviations (s.d.) or as median values.Survival was calculated by the Kaplan-Meier method,and the log-rank test assessed differences between groups.Statistically significant differences in CSS and PFS were noted among patients in T3 subgroups using the new 2010 staging system.Therefore,the revised 2010 TNM staging system can lead to a more accurate prediction of the prognosis of ccRCC patients.However,when using the revised 2010 staging system,we found that more than 92% of patients (288/313) with T3 tumours were staged in the T3a subgroup,and their survival data were not significantly different from those of patients with T2b tumours.In addition,T2 subclassification failed to independently predict survival in RCC patients.
机译:本研究旨在评估修订后的2010肿瘤节点转移(TNM)分期系统是否能够更准确地预测肾细胞癌(RCC)患者的预后预测。1216例经过根治性肾切除或部分肾切除术的1216名患者对于RCC,从2003年到2011年注册。患者的所有患者患有病理证实的透明细胞RCC(CCRCC)。所有案件在病理审查后的2002和2010年TNM分期系统中暂存,并且收集了生存数据。保险费和多元COX。保险费和多元菌回归模型用于评估手术后癌症特异性存活(CSS)和无进展的存活(PFS)。连续变量,如年龄和肿瘤直径,计算为平均值和标准偏差(SD)或作为中值值。通过KAPLAN-MEIER方法计算生存,并且对数秩检验在群体之间评估了群体之间的差异。在Patien中指出了CSS和PFS中的显着差异使用新的2010分期系统的T3子组。因此,修订后的2010 TNM分期系统可以更准确地预测CCRCC患者的预后。然而,当使用修订后的2010分期系统时,我们发现超过92%患者(288/313)在T3亚组中分阶段分阶段,它们的存活数据与T2B Tumours的患者没有显着差异。此外,T2子类化未能独立预测RCC患者的存活。

著录项

  • 来源
    《亚洲男性学杂志(英文版)》 |2013年第4期|550-557|共8页
  • 作者单位

    Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Urology, The Affiliated Hospital of Medical College Qingdao University, Qingdao 266001, China;

    Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China;

    Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Urology, The Affiliated Hospital of Medical College Qingdao University, Qingdao 266001, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:40:43
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号